Antibiotic Resistance in Helicobacter Pylori: Genetic Bases and Clinical Outcomes

Phase 3

• Conditions: Digestive System; Helicobacter Pylori

• Registration Number: PACTR202208494077478
• Lead Sponsor: Mohamed A. Metwally Benha University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

?All adult patients who are indicated for upper endoscopy.

Exclusion Criteria

?Age less than 18 years old.
?Previous H. pylori treatment.
?Consumption of antibiotics or bismuth salts in the previous four weeks.
?Consumption of antisecretory drugs or sucralfate in the previous two weeks.
?A history of bleeding or a coagulation disorder that contraindicates biopsy sampling.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Eradication of H pylori defined as H pylori stool antigen negative by ELISA test

Secondary Outcome Measures

Name	Time	Method
Eradication rate in H pyori with genetic resistant clarithromycin